Researchers Report Using CRISPR/CAS9 Genome Editing to Fix Beta Thalassemia Gene Mutations In Vitro | GenomeWeb

NEW YORK (GenomeWeb) – By using the CRISPR/Cas9 genome editing approach, researchers from the University of California, San Francisco report that they were able to correct β-thalassemia gene mutations in patient-specific iPS cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.